ZNTL - Financial Reports List - Zentalis Pharmaceuticals, Inc. - IntrinsicAlpha

Zentalis Pharmaceuticals, Inc. ZNTL

Healthcare - Biotechnology - NASDAQ - US

$ 1.4101

5.43 %

$ 101 M

Market Cap

-0.58

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	1176.85%	22.07%	26.61%
Annual Report	FY	10-K	2024-12-31	0.00%	43.24%	23.21%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	27.68%	17.99%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	21.55%	37.31%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	116.52%	61.87%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	-26.48%	-31.24%
Annual Report	FY	10-K	2023-12-31	0.00%	-32.31%	-9.55%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-6.52%	-15.73%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-78.46%	-63.75%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	-6.03%	-12.22%

1